We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+38.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$28.8B
Cap. Flow %
-4.24%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,632
Reduced
714
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 18.45%
2 Healthcare 18.09%
3 Consumer Discretionary 13.59%
4 Financials 13.39%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVVI icon
2476
Willamette Valley Vineyards
WVVI
$11.5M
$78K ﹤0.01%
10,850
GBR icon
2477
New Concept Energy
GBR
$3.69M
$69K ﹤0.01%
30,600
GSAT icon
2478
Globalstar
GSAT
$10.8B
$69K ﹤0.01%
10,627
III icon
2479
Information Services Group
III
$249M
$69K ﹤0.01%
18,462
+100
+0.5% +$412
OPCH icon
2480
Option Care Health
OPCH
$3.57B
$69K ﹤0.01%
8,623
+75
+0.9% +$986
AKAO
2481
DELISTED
Achaogen Inc
AKAO
$69K ﹤0.01%
150,229
+500
+0.3% +$525
AIOT
2482
PowerFleet Inc
AIOT
$421M
$64K ﹤0.01%
10,800
AMPE
2483
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$64K ﹤0.01%
382
ACRS icon
2484
Aclaris Therapeutics
ACRS
$860M
$63K ﹤0.01%
+10,446
New +$69.2K
SRNE
2485
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$63K ﹤0.01%
13,172
+400
+3% +$1.05K
GROW icon
2486
US Global Investors
GROW
$38.7M
$62K ﹤0.01%
56,500
OCC icon
2487
Optical Cable Corp
OCC
$149M
$60K ﹤0.01%
12,869
PXLW icon
2488
Pixelworks
PXLW
$42.3M
$60K ﹤0.01%
1,267
DRRX
2489
DELISTED
DURECT Corp
DRRX
$58K ﹤0.01%
9,246
-115
-1% -$776
QUMU
2490
DELISTED
Qumu Corp.
QUMU
$57K ﹤0.01%
23,450
+700
+3% +$1.6K
MXWL
2491
DELISTED
Maxwell Technologies Inc
MXWL
$57K ﹤0.01%
12,694
-12,600
-50% -$49.5K
PIR
2492
DELISTED
Pier 1 Imports, Inc.
PIR
$56K ﹤0.01%
3,656
WKHS icon
2493
Workhorse Group
WKHS
$33.7M
$52K ﹤0.01%
28
SALM
2494
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$52K ﹤0.01%
20,450
BRS
2495
DELISTED
Bristow Group, Inc.
BRS
$52K ﹤0.01%
47,252
INO icon
2496
Inovio Pharmaceuticals
INO
$79.6M
$51K ﹤0.01%
1,143
+9
+0.8% +$454
OTIC
2497
DELISTED
Otonomy, Inc.
OTIC
$49K ﹤0.01%
18,700
BW icon
2498
Babcock & Wilcox
BW
$1.46B
$46K ﹤0.01%
11,248
TRQ
2499
DELISTED
Turquoise Hill Resources Ltd
TRQ
$46K ﹤0.01%
2,810
TLGT
2500
DELISTED
Teligent, Inc
TLGT
$44K ﹤0.01%
3,762
+100
+3% +$1.51K

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.